| TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease SM Zekavat, V Viana-Huete, N Matesanz, SD Jorshery, MA Zuriaga, ... Nature cardiovascular research 2 (2), 144-158, 2023 | 33 | 2023 |
| Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease M Amoros-Perez, JJ Fuster Atherosclerosis 297, 120-126, 2020 | 13 | 2020 |
| TP53-mediated clonal hematopoiesis confers increased risk for incident peripheral artery disease SM Zekavat, V Viana-Huete, SD Jorshery, MA Zuriaga, MM Uddin, ... medRxiv, 2021.08. 22.21262430, 2021 | 12 | 2021 |
| Clonal hematopoiesis is not prevalent in Hutchinson-Gilford progeria syndrome M Díez-Díez, M Amorós-Pérez, J de la Barrera, E Vázquez, A Quintas, ... Geroscience 45 (2), 1231-1236, 2023 | 4 | 2023 |
| Lamin A/C expression in hematopoietic cells regulates mouse atherosclerosis: A potential mechanism contributing to age-dependent atherosclerosis M Amorós-Pérez, A Del Monte, C Rius, MJ Andrés-Manzano, C González, ... Atherosclerosis 355, 15, 2022 | | 2022 |
| No effect of radiation-related clonal hematopoiesis driven by PPM1D mutations on experimental atherosclerosis development M Amorós-Pérez, V Zorita, R Moro-Moro, N Matesanz, V Viana-Huete, ... Atherosclerosis 355, 43, 2022 | | 2022 |
| TP53-mutant clonal hematopoiesis accelerates experimental atherosclerosis development N Matesanz, V Viana-Huete, MA Zuriaga, V Zorita, A Ferrer-Pérez, ... Atherosclerosis 355, 9, 2022 | | 2022 |
| Role of DNA Damage, Somatic Mutations, Telomere Shortening, and Epigenetic Alterations in Aging and Age-Related Disease M Amorós-Pérez, ÍRP de Lara, V Andrés Academic Press, 2022 | | 2022 |
